Home › NDC Lookup › RxCUI directory › RxCUI 856696

Dantrolene sodium 0.333 MG/ML Injectable Solution — RxCUI 856696

Name: Dantrolene sodium 0.333 MG/ML Injectable Solution (RxCUI 856696)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 856696 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856696

Official nameDantrolene sodium 0.333 MG/ML Injectable Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped4

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dantrolene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Dantrolene is used for two main things. If you're taking the capsules (Dantrium or Dantrolene Sodium), it's most likely to help control muscle stiffness and spasms caused by condit...
The most serious risk is liver damage. Watch for yellowing of your skin or the whites of your eyes, very dark urine, persistent nausea, or pain in the upper right side of your abdo...
What are the most important side effects I should watch for?
Dantrolene can cause liver damage — and this is the number one safety concern with long-term use. Regular blood tests (liver function tests) are the only way to catch a problem ear...

📖 Read our full Dantrolene guide →

🕸️ Concept Web — How Dantrolene sodium 0.333 MG/ML Injectable Solutio... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dantrolene sodium 0.333 MG/ML Injectable Solution RxCUI 856696 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Dantrolene 3105 IN
- Dantrolene sodium 3106 PIN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Dantrium 3104 BN
- Revonto 1012462 BN
Dose forms 12

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dantrolene Injectable Solution 377095 SCDF
- Dantrolene sodium Injectable Solution 2646074 SCDFP
- Dantrolene Injectable Product 1151848 SCDG
- Dantrolene sodium Injectable Product 2662061 SCDGP
- Dantrolene Injectable Solution [Dantrium] 706538 SBDF
- Dantrolene Injectable Solution [Revonto] 1012464 SBDF
- Dantrolene sodium Injectable Solution [Dantrium] 2655259 SBDFP
- Dantrolene sodium Injectable Solution [Revonto] 2657925 SBDFP
- +4 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dantrolene sodium 0.333 MG/ML 856695 SCDC
- Dantrolene sodium 0.333 MG/ML Injectable Solution [Dantrium] 856698 SBD
- Dantrolene sodium 0.333 MG/ML Injectable Solution [Revonto] 1012465 SBD
- Dantrolene sodium 0.333 MG/ML [Dantrium] 856697 SBDC
- Dantrolene sodium 0.333 MG/ML [Revonto] 1012463 SBDC

Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dantrolene sodium 0.333 MG/ML SCDC · 856695
Dantrolene Injectable Solution SCDF · 377095
Dantrolene sodium Injectable Solution SCDFP · 2646074
Dantrolene Injectable Product SCDG · 1151848
Dantrolene sodium Injectable Product SCDGP · 2662061

Brand-Name Concepts

Dantrolene sodium 0.333 MG/ML Injectable Solution [Dantrium] SBD · 856698
Dantrolene sodium 0.333 MG/ML Injectable Solution [Revonto] SBD · 1012465
Dantrolene sodium 0.333 MG/ML [Dantrium] SBDC · 856697
Dantrolene sodium 0.333 MG/ML [Revonto] SBDC · 1012463
Dantrolene Injectable Solution [Dantrium] SBDF · 706538
Dantrolene Injectable Solution [Revonto] SBDF · 1012464
Dantrolene sodium Injectable Solution [Dantrium] SBDFP · 2655259
Dantrolene sodium Injectable Solution [Revonto] SBDFP · 2657925
Dantrium Injectable Product SBDG · 1168159
Revonto Injectable Product SBDG · 1183045

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 856696 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9297-01	1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9297-01)	Dantrolene	Hikma Pharmaceuticals USA Inc.	2017-06-19
42023-0123-06	6 VIAL in 1 CARTON (42023-123-06) / 60 mL in 1 VIAL	Dantrium	Par Health USA, LLC	2009-04-20
78670-0003-67	6 VIAL, GLASS in 1 CARTON (78670-003-67) / 60 mL in 1 VIAL,...	Revonto	USWM, LLC	2021-04-09
84549-0003-67	60 mL in 1 VIAL, GLASS (84549-003-67)	Revonto	ProPharma Distribution	2025-09-15

Observed labelers: Hikma Pharmaceuticals USA Inc. (1) · Par Health USA, LLC (1) · ProPharma Distribution (1) · USWM, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.